MG

Muralidharan Gopalakrishnan

Active Director Director DIN 08757306
DIN 08757306 First appointment Jun 2020 Primary industry Research & Development
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Muralidharan Gopalakrishnan

Data last updated:

Muralidharan Gopalakrishnan is a Director at Bioassistant Private Limited (since 2020). The company operates in Research & Development.

DIN 08757306
Primary Designation Director
Industry Research & Development
First Appointment 09 Jun 2020
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Bioassistant Private Limited U73100MH2020PTC340428
Director09 Jun 20202020Active

Board colleagues of Muralidharan Gopalakrishnan

NameDINCompanyDesignation
Gopalakrishnan Palani08757307Bioassistant Private LimitedDirector

Directorship timeline

Open interactive timeline →
Bioassistant Private Limited
Premium access

Shareholding and investment profile for Muralidharan Gopalakrishnan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Muralidharan Gopalakrishnan

Muralidharan Gopalakrishnan currently holds 1 directorship: Bioassistant Private Limited (Director, since 09 Jun 2020).

Muralidharan Gopalakrishnan was first appointed on 09 Jun 2020 as Director at Bioassistant Private Limited.

The current boards of Muralidharan Gopalakrishnan's companies include Gopalakrishnan Palani (Bioassistant Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available